Literature DB >> 7150869

Involvement of the median raphe nucleus in antinociception induced by morphine, buprenorphine and tilidine in the rat.

R M Bryant, J E Olley, M B Tyers.   

Abstract

1 Antinociception induced by three analgesics with differing profiles of activity, morphine, buprenorphine and tilidine, have been evaluated in the hot plate and paw pressure tests after administration by the subcutaneous route and directly into the median raphe nucleus in the conscious rat. 2 Behavioural and neurological effects of the three analgesics were also assessed. 3 The typical profiles of antinociceptive activity induced by the three analgesics were qualitatively similar after either route of administration. Morphine induced naloxone-sensitive dose-dependent effects in both tests. Buprenorphine showed naloxone-sensitive effects with a bell-shaped dose-response curve in the thermal test but dose-dependent activity in the pressure test. Tilidine induced naloxone-sensitive dose-dependent effects in the thermal test but demonstrated naloxone-insensitive activity in the paw pressure test. 4 The behavioural and neurological effects of the analgesics in the dose range used would not have affected the animals' ability to respond to the nociceptive stimuli. 5 The results suggest that the median raphe could participate in drug-induced antinociception. The mechanisms by which this might occur are discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7150869      PMCID: PMC2044677          DOI: 10.1111/j.1476-5381.1982.tb09339.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

Review 1.  Central nervous system mechanisms of analgesia.

Authors:  David J Mayer; Donald D Price
Journal:  Pain       Date:  1976-12       Impact factor: 6.961

2.  A classification of opiate receptors that mediate antinociception in animals.

Authors:  M B Tyers
Journal:  Br J Pharmacol       Date:  1980-07       Impact factor: 8.739

3.  The opiate-like action of tilidine is mediated by metabolites.

Authors:  R Schulz; J Bläsig; M Wüster; A Herz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-09       Impact factor: 3.000

Review 4.  Serotonin-containing neurons: their possible role in pain and analgesia.

Authors:  R B Messing; L D Lytle
Journal:  Pain       Date:  1977-10       Impact factor: 6.961

5.  Connections of the median and dorsal raphe nuclei in the rat: an autoradiographic and degeneration study.

Authors:  L C Conrad; C M Leonard; D W Pfaff
Journal:  J Comp Neurol       Date:  1974-07       Impact factor: 3.215

6.  Further mapping of central 5-hydroxytryptamine neurons: studies with the neurotoxic dihydroxytryptamines.

Authors:  K Fuxe; G Jonsson
Journal:  Adv Biochem Psychopharmacol       Date:  1974

7.  [Pharmacology of a new potent analgesic].

Authors:  M Herrmann; W Steinbrecher; W Heldt
Journal:  Arzneimittelforschung       Date:  1970-08

8.  Efferent connections of the habenular nuclei in the rat.

Authors:  M Herkenham; W J Nauta
Journal:  J Comp Neurol       Date:  1979-09-01       Impact factor: 3.215

9.  Agonist and antagonist properties of buprenorphine, a new antinociceptive agent.

Authors:  A Cowan; J W Lewis; I R Macfarlane
Journal:  Br J Pharmacol       Date:  1977-08       Impact factor: 8.739

10.  Effects of pain-attenuating brain stimulation and morphine on electrical activity in the raphe nuclei of the awake rat.

Authors:  Terrence D Oleson; Dennis A Twombly; John C Liebeskind
Journal:  Pain       Date:  1978-02       Impact factor: 6.961

View more
  3 in total

1.  The relative significance of spinal and supraspinal actions in the antinociceptive effect of morphine in the dorsal horn: an evaluation of the microinjection technique.

Authors:  S L Clark; R O Edeson; R W Ryall
Journal:  Br J Pharmacol       Date:  1983-07       Impact factor: 8.739

2.  Antinociceptive actions of morphine and buprenorphine given intrathecally in the conscious rat.

Authors:  R M Bryant; J E Olley; M B Tyers
Journal:  Br J Pharmacol       Date:  1983-04       Impact factor: 8.739

Review 3.  Recent Advancement in Topical Nanocarriers for the Treatment of Psoriasis.

Authors:  Prativa Biswasroy; Deepak Pradhan; Biswakanth Kar; Goutam Ghosh; Goutam Rath
Journal:  AAPS PharmSciTech       Date:  2021-05-26       Impact factor: 3.246

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.